You can’t fully unclog arteries once plaque has built up, but you can shrink plaque, stabilize it so it’s less likely to rupture, and in some cases partially reverse the narrowing. The key threshold: getting LDL cholesterol below about 70 mg/dL is where arteries tend to stop getting worse and may start improving. A combination of dietary changes, exercise, cholesterol-lowering medication, and inflammation control gives you the best shot at meaningful reversal.
What “Unclogging” Actually Means
Plaque regression isn’t like clearing a clogged drain. The buildup inside your artery walls is a complex mix of cholesterol, immune cells, calcium, and scar tissue that developed over years or decades. Complete reversal to a clean, original artery wall isn’t possible. What is possible is shrinking the fatty core of the plaque, strengthening the cap that covers it, and reducing the inflammation that makes plaque dangerous.
The real risk from plaque isn’t just the narrowing itself. It’s when an unstable plaque ruptures, triggering a blood clot that blocks the artery entirely. That’s what causes most heart attacks. So the goal is twofold: reduce plaque volume where possible and make whatever plaque remains more stable and less likely to cause a sudden event.
Your body does have a natural cleanup system. HDL cholesterol particles act as scavengers, pulling cholesterol out of the cells embedded in artery walls and ferrying it back to the liver for disposal. Boosting this process, called cholesterol efflux, is one of the main biological mechanisms behind plaque shrinkage.
The LDL Target That Triggers Reversal
Multiple imaging studies using ultrasound inside coronary arteries have pinpointed the cholesterol levels where plaque stops growing and starts shrinking. At an LDL of around 80 mg/dL, plaque progression halts. At 70 mg/dL, the balance tips toward regression. And at 53 mg/dL, one major trial showed significant plaque shrinkage in people with stable coronary artery disease. The most aggressive results came at an LDL of 36 mg/dL, where adding a newer injectable cholesterol drug to statin therapy produced the greatest reduction in plaque volume.
The 70 mg/dL threshold is particularly important because it appears in guidelines across the U.S., Europe, and Japan as the target for people with established heart disease. It represents the approximate tipping point from progression to regression.
Lifestyle Changes That Move the Needle
The Ornish Lifestyle Heart Trial remains one of the most striking demonstrations of what intensive lifestyle changes can accomplish. Participants followed a very low-fat vegetarian diet, exercised regularly, practiced stress management, and attended group support sessions. After one year, artery narrowing decreased by 1.75 percentage points. After five years, it decreased by 3.1 percentage points, a 7.9% relative improvement. Meanwhile, the comparison group who made only moderate changes saw their blockages worsen by 11.8 percentage points over five years, a 27.7% relative worsening. The lifestyle group also had roughly half as many cardiac events.
A Mediterranean diet offers benefits without such extreme restrictions. In a substudy of the large PREDIMED trial, people who followed a Mediterranean diet supplemented with nuts saw their carotid artery wall thickness decrease, while the control group’s arteries got thicker. The nut-enriched Mediterranean group also showed a reduction in maximum plaque height. Across the full trial, this eating pattern cut the combined risk of cardiovascular death, heart attack, and stroke by 30%, with stroke risk dropping by 49%.
Exercise Requirements
Aerobic exercise reduces arterial stiffness, which is both a consequence and a driver of plaque buildup. A controlled study found that exercising just three times per week for eight weeks significantly improved arterial flexibility. Both low-intensity and moderate-intensity sessions produced measurable benefits, and even 15 minutes per session was enough to see changes. Longer sessions (30 minutes) at moderate intensity produced the best results, but the takeaway is that the bar for meaningful improvement is lower than many people assume.
How Medications Shrink Plaque
High-intensity statin therapy is the foundation. In imaging studies, statins alone reduced plaque volume by about 1% on average. Adding a second cholesterol-absorbing medication roughly doubled that reduction to about 2%. Adding a PCSK9 inhibitor, a newer injectable drug that dramatically lowers LDL, produced a similar 2.1% reduction. The difference between the two add-on approaches wasn’t statistically significant, so the choice often comes down to cost, convenience, and how much LDL lowering you need.
These percentage changes in plaque volume may sound small, but they represent a meaningful shift from progression to regression. The clinical payoff is substantial: fewer heart attacks, fewer strokes, and fewer procedures down the road.
Why Inflammation Matters as Much as Cholesterol
Cholesterol is the raw material of plaque, but inflammation is what makes plaque grow and become unstable. A landmark trial called CANTOS tested an anti-inflammatory drug in people who already had well-controlled cholesterol and found that reducing inflammation alone lowered cardiovascular risk. Patients whose blood inflammation markers dropped below a certain level saw the greatest benefit.
More recently, colchicine, an old anti-inflammatory drug originally used for gout, has shown promise. A meta-analysis of clinical trials found that colchicine reduced the risk of major cardiovascular events by 26%, heart attacks by 15%, and strokes by 21% when added to statin therapy. Nearly all participants in these trials were already on statins, so the anti-inflammatory effect provided benefit on top of cholesterol lowering.
When Procedures Are Necessary
Lifestyle changes and medications work on a timeline of months to years. When arteries are severely blocked and causing symptoms like chest pain or shortness of breath, or when blood flow is critically restricted, procedures can restore flow immediately.
Angioplasty with stenting threads a small balloon into the blocked artery, inflates it to compress the plaque, and leaves a mesh tube (stent) to keep the artery open. This is typically recommended when one or two arteries are significantly blocked and symptoms persist despite medication.
Bypass surgery reroutes blood flow around the blockage using a vessel grafted from another part of your body. It’s generally preferred when three or more arteries are blocked, when the main left coronary artery is heavily narrowed, or when you have diabetes or weakened heart function alongside multi-vessel disease. In cases where the blockage pattern is complex, scoring systems help determine which approach gives the best long-term outcome. For less complex patterns, you and your cardiologist can weigh the tradeoffs and choose together.
Neither procedure “unclogs” the artery in the way people imagine. Stenting pushes plaque aside and holds the artery open. Bypass creates a detour. Both address the immediate flow problem but don’t eliminate the underlying disease, which is why medications and lifestyle changes remain essential afterward.
Knowing Where You Stand
A coronary calcium scan is a quick, low-radiation CT scan that measures calcified plaque in your heart’s arteries. Results come as an Agatston score. A score of zero means no detectable calcium, suggesting low near-term heart attack risk. A score of 100 to 300 indicates moderate plaque deposits and a relatively high risk of heart attack or other cardiovascular event within the next three to five years. A score above 300 signals more extensive disease and higher risk. Your score can also be compared to others of the same age and sex; ranking at the 75th percentile or above is linked to significantly higher heart attack risk.
This score is useful for people in a gray zone of risk, where it’s unclear whether aggressive treatment is warranted. It can also serve as a motivational baseline, though repeat scans to track changes aren’t routinely recommended because calcium scores can paradoxically rise even as plaque stabilizes on medication.
Putting It All Together
The most effective approach to reversing arterial plaque combines several strategies simultaneously. Drop your LDL below 70 mg/dL, and ideally lower, through diet, statins, or additional medications as needed. Adopt a plant-heavy, Mediterranean-style eating pattern rich in nuts, olive oil, vegetables, and fish. Exercise at least three times per week for 15 to 30 minutes at moderate intensity. Address inflammation, which your doctor can assess with a high-sensitivity CRP blood test.
The Ornish trial showed that more regression happened between years one and five than in the first year alone, while the comparison group steadily worsened. That’s the essential message: arterial disease is a slow process in both directions. Consistent changes sustained over years produce compounding benefits, while doing nothing allows plaque to quietly and relentlessly progress.